News Sentiment

ELIC sentiment intelligence

Elicera Therapeutics AB (publ) news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 50 Balanced news tone 2 relevant articles
Exchange STO Sweden
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 2.77 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

58/100 classification confidence.

Company focus 2

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-5.6% over one week, +3.9% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

BioVal™ analysis: Elicera Therapeutics' ELC-301 valued at SEK 631M

Market Reaction

Price moving ahead of tone

50/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 58/100 classification
One-week reaction -5.6% Price reacting lower
Trend fit Trend inactive 3.9% over four weeks
Fair value -22.8% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 0
Neutral 2
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 2
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Biostock 1
simplywall.st 1

Event Lens

What the news is about

Classified themes
Market update 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-2 of 2